Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2013 February;68(1) > Minerva Chirurgica 2013 February;68(1):27-39

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CHIRURGICA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,877


eTOC

 

  COLORECTAL CANCER


Minerva Chirurgica 2013 February;68(1):27-39

language: English

Minimally invasive treatment of colorectal liver metastases

Darwazeh G. 1, Prada Villaverde A. 2, Kowdley G. C. 1, Cunningham S. C. 1

1 Department of Surgery, Saint Agnes Hospital, Baltimore, MD, USA;
2 Department of Surgery, Hospital Infanta Cristina, Badajoz, Spain


PDF  


Minimally invasive approaches are increasingly used in the treatment of colorectal liver metastases (CRLMs) and for increasingly complex cases. Herein, we review the spectrum of modalities used in the minimally invasive treatment of CRLM, focusing on one of the newest approaches, robotic liver resection, and on local regional therapies, both operative and percutaneous. Oncologic outcomes after minimally invasive therapies are also evaluated. Although there are no randomized trials comparing minimally invasive liver resection to open resection, an increasing quantity of nonrandomized data suggest favorable outcomes with a minimally invasive approach. The future of minimally invasive treatment of CRLM will likely include specifying training and credentialing criteria as well as an enlarging role for the combined surgical treatment of CRLM and extrahepatic colorectal metastases.

top of page

Publication History

Cite this article as

Corresponding author e-mail

steven.cunningham@stagnes.org